Showing results 1 to 12 of 12
A Chemically Induced Vaccine Strategy for Prostate Cancer Dubrovska, Anna; Kim, Chan Hyuk; Elliott, Jimmy; Shen, Weijun; Kuo, Tun-Hsun; Koo, Dong-In; Li, Chun; et al, ACS CHEMICAL BIOLOGY, v.6, no.11, pp.1223 - 1231, 2011-11 |
A small-sized protein binder specific for human PD-1 effectively suppresses the tumour growth in tumour mouse model Son, Sumin; Park, Jinho; Seo, Hyo Deok; Lee, Hyun Tae; Heo, Yong-Seok; Kim, Hak-Sung, JOURNAL OF DRUG TARGETING, v.28, no.4, pp.419 - 427, 2020-04 |
Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells![]() Miao, Yuxuan; Yang, Hanseul; Levorse, John; Yuan, Shaopeng; Polak, Lisa; Sribour, Megan; Singh, Bhuvanesh; et al, CELL, v.177, no.5, pp.1172 - +, 2019-05 |
An Anti-B Cell Maturation Antigen Bispecific Antibody for Multiple Myeloma Ramadoss, Nitya S.; Schulman, Andrew D.; Choi, Sei-hyun; Rodgers, David T.; Kazane, Stephanie A.; Kim, Chan Hyuk; Lawson, Brian R.; et al, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, v.137, no.16, pp.5288 - 5291, 2015-04 |
Bispecific small molecule-antibody conjugate targeting prostate cancer Kim, Chan Hyuk; Axup, Jun Y.; Lawson, Brian R.; Yun, Hwayoung; Tardif, Virginie; Choi, Sei Hyun; Zhou, Quan; et al, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, v.110, no.44, pp.17796 - 17801, 2013-10 |
Carbon Nanosyringe Array as a Platform for Intracellular Delivery Park, Sangjin; Kim, Youn-Su; Kim, Won Bae; Jon, Sangyong, NANO LETTERS, v.9, no.4, pp.1325 - 1329, 2009-04 |
Engineering of Surface Energy of Cell-Culture Platform to Enhance the Growth and Differentiation of Dendritic Cells via Vapor-Phase Synthesized Functional Polymer Films Lee, Minseok; Chun, Dongmin; Park, Seonghyeon; Choi, Goro; Kim, Yesol; Kang, Suk-Jo; Im, Sung Gap, SMALL, v.18, no.17, pp.2106648, 2022-04 |
Enhanced half-life and antitumor activity of interleukin-15 through genetic fusion of a serum albumin-specific protein binder Kim, Dasom; Park, Jin-Ho; Kim, Tae-Yoon; Kim, Dong-Gun; Byun, June-Ho; Kim, Hak-Sung, INTERNATIONAL JOURNAL OF PHARMACEUTICS, v.625, 2022-09 |
Evolution of chimeric antigen receptor (CAR) T cell therapy: current status and future perspectives Lee, Young-Ho; Kim, Chan Hyuk, ARCHIVES OF PHARMACAL RESEARCH, v.42, no.7, pp.607 - 616, 2019-07 |
Harnessing type I interferon-mediated immunity to target malignant brain tumors Lim, Juhee; Kang, In; La, Jeongwoo; Ku, Keun Bon; Kang, Byeong Hoon; Kim, Yumin; Park, Won Hyung; et al, FRONTIERS IN IMMUNOLOGY, v.14, 2023-05 |
Redirection of CAR-T Cell Cytotoxicity Using Metabolic Glycan Labeling with Unnatural Sugars Cha, Jeong Hyeon; Kim, Eunsu; Lee, Hyeong Ji; Lee, Young-Ho; Lee, Jeonghyun; Kim, Eunha; Kim, Chan Hyuk, JOURNAL OF MEDICINAL CHEMISTRY, v.66, no.12, pp.7804 - 7812, 2023-06 |
Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules Kim, Min Soo; Ma, Jennifer S. Y.; Yun, Hwayoung; Cao, Yu; Kim, Ji Young; Chi, Victor; Wang, Danling; et al, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, v.137, no.8, pp.2832 - 2835, 2015-03 |
Discover